MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme

被引:107
|
作者
Suh, Sung-Suk [1 ]
Yoo, Ji Young [2 ]
Nuovo, Gerard J. [1 ]
Jeon, Young-Jun [1 ]
Kim, Seokho [3 ]
Lee, Tae Jin [1 ]
Kim, Taewan [1 ]
Bakacs, Arianna [4 ]
Alder, Hansjuerg [1 ]
Kaur, Balveen [2 ]
Aqeilan, Rami I. [1 ,5 ]
Pichiorri, Flavia [6 ]
Croce, Carlo M. [1 ]
机构
[1] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Ctr Comprehens Canc, Columbus, OH 43210 USA
[2] Ohio State Univ, Dardinger Lab Neurooncol & Neurosci, Dept Neurol Surg, Comprehens Canc Ctr,Med Ctr, Columbus, OH 43220 USA
[3] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA
[4] Azienda Complesso Osped San Filippo Neri, Unita Operat Complessa Anat Patol, I-00135 Rome, Italy
[5] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Dept Immunol & Canc Res,Inst Med Res Israel Canad, IL-91120 Jerusalem, Israel
[6] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA
关键词
GROWTH-FACTOR RECEPTOR; CELL-CYCLE ARREST; C-MYC; PROMOTES APOPTOSIS; DOWN-REGULATION; P53; GENE; MDM2; INHIBITION; EXPRESSION; CANCER;
D O I
10.1073/pnas.1202465109
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MicroRNAs (miRNAs) are increasingly implicated in regulating cancer initiation and progression. In this study, twomiRNAs, miR-25 and -32, are identified as p53-repressed miRNAs by p53-dependent negative regulation of their transcriptional regulators, E2F1 and MYC. However, miR-25 and -32 result in p53 accumulation by directly targeting Mdm2 and TSC1, which are negative regulators of p53 and the mTOR (mammalian target of rapamycin) pathway, respectively, leading to inhibition of cellular proliferation through cell cycle arrest. Thus, there is a recurrent autoregulatory circuit involving expression of p53, E2F1, and MYC to regulate the expression of miR-25 and -32, which are miRNAs that, in turn, control p53 accumulation. Significantly, overexpression of transfectedmiR-25 and -32 in glioblastoma multiforme cells inhibited growth of the glioblastoma multiforme cells in mouse brain in vivo. The results define miR-25 and -32 as positive regulators of p53, underscoring their role in tumorigenesis in glioblastoma.
引用
收藏
页码:5316 / 5321
页数:6
相关论文
共 50 条
  • [1] CLL pathogenesis: novel microRNA/TP53 feedback circuitry
    Lisa Hutchinson
    Nature Reviews Clinical Oncology, 2011, 8 (3) : 125 - 125
  • [2] TP53 or Not TP53: That Is the Question
    Green, Steven D.
    Zeidner, Joshua F.
    CLINICAL CANCER RESEARCH, 2022, 28 (24) : 5235 - 5237
  • [3] Advances in microRNAs and TP53 Gene Regulatory Network
    Gong Zhao-Jian
    Huang Hong-Bin
    Xu Ke
    Liang Fang
    Li Xiao-Ling
    Xiong Wei
    Zeng Zhao-Yang
    Li Gui-Yuan
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2012, 39 (12) : 1133 - 1144
  • [4] TP53 Promoter Methylation in Primary Glioblastoma: Relationship with TP53 mRNA and Protein Expression and Mutation Status
    Jesionek-Kupnicka, Dorota
    Szybka, Malgorzata
    Malachowska, Beata
    Fendler, Wojciech
    Potemski, Piotr
    Piaskowski, Sylwester
    Jaskolski, Dariusz
    Papierz, Wielislaw
    Skowronski, Wieslaw
    Och, Waldemar
    Kordek, Radzislaw
    Zawlik, Izabela
    DNA AND CELL BIOLOGY, 2014, 33 (04) : 217 - 226
  • [5] Extraneural Metastasis of Glioblastoma and TP53 Pathogenic Variants
    Zhang, Xiaoming
    Katsakhyan, Levon
    LiVolsi, Virginia
    Roth, Jacquelyn
    Rassekh, Christopher
    Bagley, Stephen
    Nasrallah, MacLean
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 575 - 575
  • [6] Immunohistochemical Analysis of TP53 and PTEN Expression in Glioblastoma Multiforme Patients of Western Rajasthan, India: An Observational Study
    Garima
    Thanvi, Sharad
    Elhence, Poonam
    Khatri, Kishore
    Verma, Roshan
    Verma, Vijay
    Toshniwal, Hanuman Prasad
    Sharma, Shailendra
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (08) : EC6 - EC11
  • [7] Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia
    Fabbri, Muller
    Bottoni, Arianna
    Shimizu, Masayoshi
    Spizzo, Riccardo
    Nicoloso, Milena S.
    Rossi, Simona
    Barbarotto, Elisa
    Cimmino, Amelia
    Adair, Brett
    Wojcik, Sylwia E.
    Valeri, Nicola
    Calore, Federica
    Sampath, Deepa
    Fanini, Francesca
    Vannini, Ivan
    Musuraca, Gerardo
    Dell'Aquila, Marie
    Alder, Hansjuerg
    Davuluri, Ramana V.
    Rassenti, Laura Z.
    Negrini, Massimo
    Nakamura, Tatsuya
    Amadori, Dino
    Kay, Neil E.
    Rai, Kanti R.
    Keating, Michael J.
    Kipps, Thomas J.
    Calin, George A.
    Croce, Carlo M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (01): : 59 - 67
  • [8] The status of MGMT methylation and TP53 mutations in patients with glioblastoma
    Jesionek-Kupnicka, Dorota
    Zawlik, Izabela
    Jesien-Lewandowicz, Emilia
    Szybka, Malgorzata
    Kulczycka, Dominika
    Kusinska, Renata
    Kordek, Radzislaw
    VIRCHOWS ARCHIV, 2008, 452 : S153 - S154
  • [9] MGMT promoter methylation and TP53 gene mutations in glioblastoma
    Zawlik, I.
    Jesionek-Kupnicka, D.
    Jesien-Lewandowicz, E.
    Szybka, M.
    Kulczycka-Wojdala, D.
    Rieske, P.
    Liberski, P. P.
    Kordek, R.
    EJC SUPPLEMENTS, 2008, 6 (09): : 115 - 115
  • [10] The status of MGMT methylation and TP53 mutations in patients with glioblastoma
    Jesionek-Kupnicka, Dorota
    Zawlik, Izabela
    Jesien-Lewandowicz, Emilia
    Szybka, Malgorzata
    Kulczycka, Dominika
    Kusinska, Reneta
    Pasz-Walczak, Grazyna
    Kordek, Radzislaw
    VIRCHOWS ARCHIV, 2007, 451 (02) : 240 - 240